Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.03% |
| 2 | Energy | 10.22% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 9.09% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Lisata Therapeutics
LSTA
$11.9M
| $214K | ﹤0.01% |
1,319
+535
| +68% | +$98.2K |
|
3052
Prothena Corp
PRTA
$440M
| $213K | ﹤0.01% |
3,134
-280,788
| -99% | -$16.9M |
|
3053
Titan Machinery
TITN
$467M
| $213K | ﹤0.01% |
19,450
+5,796
| +42% | +$67.3K |
|
3054
Atara Biotherapeutics
ATRA
$69.7M
| $212K | ﹤0.01% |
+321
| New | +$243K |
|
|
ESND
3055
DELISTED
Essendant Inc.
ESND
| $211K | ﹤0.01% |
6,490
-173,490
| -96% | -$5.91M |
|
3056
Raymond James Financial
RJF
$34.2B
| $210K | ﹤0.01% |
5,442
-369,459
| -99% | -$13.8M |
|
|
NSM
3057
DELISTED
Nationstar Mortgage Holdings
NSM
| $210K | ﹤0.01% |
15,692
-165,477
| -91% | -$2.2M |
|
|
FENG
3058
Phoenix New Media
FENG
$17.5M
| $209K | ﹤0.01% |
5,775
+1,286
| +29% | +$37.8K |
|
3059
Landstar System
LSTR
$6.35B
| $209K | ﹤0.01% |
3,572
-5,822
| -62% | -$359K |
|
|
AXAS
3060
DELISTED
Abraxas Petroleum Corp
AXAS
| $209K | ﹤0.01% |
9,840
+8,420
| +593% | +$231K |
|
|
ARR
3061
Armour Residential REIT
ARR
$2.01B
| $208K | ﹤0.01% |
1,914
-45,322
| -96% | -$4.76M |
|
3062
Arrow Electronics
ARW
$10.7B
| $208K | ﹤0.01% |
3,838
-596,881
| -99% | -$34M |
|
3063
Ceco Environmental
CECO
$3.97B
| $208K | ﹤0.01% |
27,073
-60,777
| -69% | -$514K |
|
|
RBY
3064
DELISTED
RUBICON MENERALS CORP (F)
RBY
| $208K | ﹤0.01% |
2,286,487
+647,980
| +40% | +$168K |
|
3065
AudioCodes
AUDC
$249M
| $207K | ﹤0.01% |
+53,060
| New | +$206K |
|
3066
Rapid7
RPD
$659M
| $207K | ﹤0.01% |
13,661
+661
| +5% | +$12.5K |
|
3067
Urban One Class D
UONEK
$23.5M
| $206K | ﹤0.01% |
11,978
-3,166
| -21% | -$62.4K |
|
|
ATXS
3068
DELISTED
Astria Therapeutics
ATXS
| $205K | ﹤0.01% |
431
-635
| -60% | -$305K |
|
3069
Invesco Biotechnology & Genome ETF
PBE
$286M
| $205K | ﹤0.01% |
+4,050
| New | +$200K |
|
|
ESIO
3070
DELISTED
Electro Scientific Industries
ESIO
| $205K | ﹤0.01% |
39,417
-22,907
| -37% | -$115K |
|
|
GUID
3071
DELISTED
Guidance Software, Inc.
GUID
| $205K | ﹤0.01% |
34,077
-20,027
| -37% | -$118K |
|
|
WIN
3072
DELISTED
Windstream Holdings Inc
WIN
| $203K | ﹤0.01% |
6,294
-6,288
| -50% | -$202K |
|
|
EVOK
3073
DELISTED
Evoke Pharma
EVOK
| $202K | ﹤0.01% |
426
+69
| +19% | +$35.1K |
|
3074
iShares Europe ETF
IEV
$1.65B
| $202K | ﹤0.01% |
+5,033
| New | +$208K |
|
|
CONN
3075
DELISTED
Conn's Inc.
CONN
| $202K | ﹤0.01% |
+8,607
| New | +$204K |
|
Similar funds
Millennium Management's Q4 2015 Portfolio in Review
As of Q4 2015, Millennium Management held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Millennium Management withdrew a net $5.89B in Q4 2015, closing 779 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Energy and Consumer Discretionary.
Against the trend, Millennium Management opened a new position in Alphabet (Google) Class A worth $221M.
- Millennium Management's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Millennium Management added most to Merck in Q4 2015, an estimated $216M increase.
- Millennium Management's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Millennium Management fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Millennium Management's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Millennium Management opened 733 new positions and closed 779 in Q4 2015.
- Millennium Management's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.